Adopting new technology is crucial if the pharmaceutical industry is to measurably improve drug development efficiency. Elisa Cascade (President, Data Solutions, DrugDev) expands upon an article in the October 2015 Global Forum she co-authored with Dr. Claire Sears (DrugDev Director of Investigator Engagement) and discusses in detail the findings from a 2015 survey of DrugDev network investigators to answer the question: With sponsors, regulatory authorities, CROs, and technology companies all working together, are sites, globally, prepared to implement new clinical trial technologies?